12 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Feb 2029. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Feb 2029
Next term end
5
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Feb 2029 · High confidence
Also notable
Ends Jun 2032 · High confidence
Also notable
Ends Jan 2031 · Medium confidence
Compositions and Methods of Making Sustained Release Liquid Formulations
US 8,318,210
The most cited patent in this portfolio, cited by 113 later US patents, top 5% of utility patents granted in 2012 in our data. Protection runs to 2029.
Composition Comprising a Mixture of Dextro- and Levo- Amphetamines Complexed with Ion-Exchange Resin Particles to Form Drug Resin Particles
US 8,709,491
Cited by 65 later US patents, top 10% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2032.
Methods of Formulating and Designing Liquid Drug Suspensions Containing Ion Exchange Resin Particles
US 9,057,675
Cited by 30 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Jan 7 to 28, 2027 · next Jan 7
- 1 fee due Aug 23, 2027The maintenance fee for Pharmaceutical Composition Comprising Amphetamines Complexed with Ion-Exchange Resin Particles (US 9,265,737) comes due Aug 23, 2027. Unpaid by Feb 23, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 4 largest of its 5 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,318,210 | Compositions and Methods of Making Sustained Release Liquid Formulations In force · High confidence | In force | High confidence | |
| US 8,313,770 | Modifying Drug Release in Suspensions of Ionic Resin Systems In force · High confidence | In force | High confidence | |
| US 8,470,375 | Method of Formulating and Designing Liquid Drug Suspensions Containing Ion Exchange Resin Particles In force · High confidence | In force | High confidence | |
| US 8,512,759 | Methods of Formulating and Designing Liquid Drug Suspensions Containing Ion Exchange Resin Particles In force · High confidence | In force | High confidence | |
| US 9,057,675 | Methods of Formulating and Designing Liquid Drug Suspensions Containing Ion Exchange Resin Particles In force · Medium confidence | In force | Medium confidence | |
| US 8,709,491 | Composition Comprising a Mixture of Dextro- and Levo- Amphetamines Complexed with Ion-Exchange Resin Particles to Form Drug Resin Particles In force · High confidence | In force | High confidence | |
| US 9,017,731 | Composition Comprising a Mixture of Dextro -And Levo-Amphetamines Complexed with Ion-Exchange Resin Particles to Form Drug Resin Particles In force · High confidence | In force | High confidence | |
| US 9,072,680 | Compositions Comprising Methylphenidate Complexed with Ion-Exchange Resin Particles In force · High confidence | In force | High confidence | |
| US 9,089,496 | Compositions Comprising Methylphenidate Complexed with Ion-Exchange Resin Particles In force · High confidence | In force | High confidence | |
| US 9,265,737 | Pharmaceutical Composition Comprising Amphetamines Complexed with Ion-Exchange Resin Particles In force · High confidence | In force | High confidence |
Also on record, not counted in the 12: 2 patents ended · 11 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.